Onychomycosis: Epidemiology, diagnosis, and treatment in a changing landscape

Keyphrases

• Epidemiology 100%
• Onychomycosis 100%
• Healthcare Professionals 33%
• Low Risk 33%
• Peripheral Vascular Disease 33%
• Demographic Characteristics 33%
• Population Aging 33%
• Quality of Life Impact 33%
• New Treatment Options 33%
• Increasing Prevalence 33%
• Changes in Lifestyle 33%
• Knowledge Level 33%
• Risk Treatment 33%
• Diabetes Prevalence 33%
• Undertreated 33%
• Bacterial Superinfection 33%
• Changing Demographics 33%
• Lifestyle Practices 33%
• Tavaborole 33%
• Onychomycosis Treatment 33%
• Efinaconazole 33%
• Participation in Sport 33%
• Tinea Corporis 33%
• Iatrogenic Immunosuppression 33%
• Tinea Cruris 33%
• Relative Ageing 33%

Medicine and Dentistry

• Cohort Effect 100%
• Onychomycosis 100%
• Prevalence 50%
• Immunosuppressive Treatment 25%
• Quality of Life 25%
• Diabetes 25%
• Disease 25%
• Health Care Provider 25%
• Lifestyle Modification 25%
• Peripheral Vascular Disease 25%
• Demography 25%
• Tavaborole 25%
• Bacterial Superinfection 25%
• Efinaconazole 25%
• Tinea cruris 25%
• Tinea corporis 25%

Nursing and Health Professions

• Onychomycosis 100%
• Prevalence 50%
• Immunosuppressive Treatment 25%
• Quality of Life 25%
• Lifestyle Modification 25%
• Disease 25%
• Health Care Personnel 25%
• Food and Drug Administration 25%
• Bacterial Superinfection 25%
• Peripheral Vascular Disease 25%
• Tavaborole 25%
• Tinea corporis 25%
• Efinaconazole 25%
• Tinea cruris 25%